m+Medelevator.RU
← Поиск публикаций
Computer methods and programs in biomedicine · 2026

Synaptic regulatory flux dynamics: Stiffness and homeostatic failure in Alzheimer's disease.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Srimaharaj Wanus

Аннотация

BACKGROUND: Traditional electroencephalographic analysis in Alzheimer Disease focuses on spectral slowing, a terminal phenotype that overlooks the preceding functional failure of homeostasis. This study introduces Synaptic Regulatory Flux Dynamics (SRFD), a computational framework that models the EEG signal as a physical trajectory governed by the interplay between Excitatory Drive (E) and Regulatory Flux (R).

METHODS: Resting state EEG recordings from 88 participants (36 CE, 23 Frontotemporal Dementia [FTD], and 29 Cognitively Normal [CN]) were analyzed. The study derived novel biophysical metrics, including Instantaneous Homeostatic Error (IHE) and the Synaptic Stiffness Index (SSI), to assess the integrity of the excitation inhibition (E/I) balance.

RESULTS: It found that the AD cohort exhibited a statistically significant elevation in Mean IHE compared to controls (0.557vs0.535; p=0.0115), indicating a systemic failure of inhibitory interneurons to clamp excitatory transients. This flux decoupling was accompanied by a reduced Synaptic Stiffness Index (p=0.011), predominantly affecting posterior beta band networks. Furthermore, the framework successfully differentiated the metabolic silence of AD from the high energy, disorganized hyperexcitability of FTD.

CONCLUSION: Synaptic Regulatory Flux Dynamics provides a noninvasive, mechanistic biomarker of synaptic fragility that precedes gross atrophy. By evaluating the loss of regulatory stiffness, this framework offers a functional window into the early pathophysiology of neurodegeneration, potentially enhancing early detection and therapeutic monitoring.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты